Preoperative serum HIF-1α, HIF-2α and YKL-40, especially the combination of HIF-1α and YKL-40, have a predictive value for the degree of VInv and cancer recurrence in FTC patients. The gene discussed is HIF1A; the disease is thyroid cancer, nonmedullary, 2.